Related Experiment Video

Updated: Oct 20, 2026

Prehospital Thrombolysis: A Manual from Berlin
05:52

Prehospital Thrombolysis: A Manual from Berlin

Published on: November 26, 2013

Thrombolysis, stroke units and other strategies for reducing acute stroke costs

T H Wein1, S L Hickenbottom, A V Alexandrov

  • 1Department of Neurology, University of Texas-Houston Medical School, USA. twein@neuro.med.uth.tmc.edu

Pharmacoeconomics
|May 27, 1999
PubMed

Insights

Recombinant tissue plasminogen activator (rt-PA) therapy can significantly reduce stroke treatment costs and improve patient outcomes. Specialized stroke care, including stroke units, further enhances these benefits by decreasing hospital stays and dependency.

Area of Science:

  • Neurology
  • Health Economics
  • Public Health

Background:

  • Stroke is a leading cause of disability and mortality in the US, incurring substantial healthcare costs.
  • Current stroke treatments, such as intravenous recombinant tissue plasminogen activator (rt-PA), show promise in improving patient outcomes.
  • The economic impact of stroke necessitates exploring cost-effective treatment and care strategies.

Purpose of the Study:

  • To evaluate the cost-effectiveness of rt-PA therapy for acute ischemic stroke.
  • To assess the projected financial savings associated with rt-PA treatment.
  • To explore the role of specialized stroke care in improving patient outcomes and reducing healthcare expenditures.

Main Methods:

  • Utilized a Markov model to analyze the National Institute of Neurological Disease and Stroke (NINDS) rt-PA Stroke Study data.
  • Examined projected savings based on decreased hospital length of stay, rehabilitation, and nursing home costs.
  • Reviewed meta-analysis findings on the impact of stroke units and multidisciplinary stroke teams.

Main Results:

  • Projected savings of $US4 to $US5 million per 1000 patients treated with rt-PA.
  • rt-PA therapy demonstrated improvements in quality-adjusted life-years and increased direct-to-home discharges.
  • Stroke units were found to decrease length of hospital stay, mortality, and patient dependency.

Conclusions:

  • rt-PA therapy offers significant cost benefits and improves outcomes for eligible ischemic stroke patients.
  • Specialized stroke care, including stroke units, can further reduce healthcare costs and enhance patient recovery.
  • Expanding access to standardized, specialized stroke care is crucial for maximizing economic and clinical benefits, especially for the majority not eligible for thrombolysis.

More Related Videos

Setting Up a Stroke Team Algorithm and Conducting Simulation-based Training in the Emergency Department - A Practical Guide09:52

Setting Up a Stroke Team Algorithm and Conducting Simulation-based Training in the Emergency Department - A Practical Guide

Published on: January 15, 2017

Optimized Management of Endovascular Treatment for Acute Ischemic Stroke09:21

Optimized Management of Endovascular Treatment for Acute Ischemic Stroke

Published on: January 18, 2018

Related Concept Videos

Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care01:29

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants01:18

Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants

Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Venous Thrombosis IV: Nursing Management01:30

Venous Thrombosis IV: Nursing Management

Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...